Harrow Health, Inc.
- HROW
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Ophthalmic Pharmaceuticals (Compounding)
$27.28
Today −5.11%Quote Oct 16, 2026, 08:00 PM UTC
−17.66%over the last month
Max drawdown −20.9%From 1-month high −20.8%3 months −38.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.02B
Quote Oct 16
Next earnings
Nov 9
Expected, not confirmed
Analyst target
$66.50
+143.8% from here
Floor
$27.10
0.7% below price
Where the price sits
10 analysts
Analyst range, low to high
$45.00$88.00
- Price $27.28
- Resistance $29.26
- Consensus $66.50
The price is just above its floor. Analysts' average target sits about 144% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about HROWPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Drug Manufacturers - Specialty & Generic
Employees
373
Founded
2006